Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure. Nephrol Dial Transplant 2023 Jul 31;38(8):1912-1914
Date
03/23/2023Pubmed ID
36948600Pubmed Central ID
PMC10387392DOI
10.1093/ndt/gfad058Scopus ID
2-s2.0-85166383260 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Cho WJ, Harden D, Moreno D, Dinulos JE, Hanna PE, Wang Q, Kim AY, Sise MEAuthor
Paul E. Hanna MD Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antiviral AgentsHumans
Hydroxylamines
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Ritonavir
